Bioptigen Completes Series A Round Funding Investment Closes at $1.3 Million
FOR IMMEDIATE RELEASE August 7, 2006
Contact: Winn Maddrey 704.905.2912
BIOPTIGEN COMPLETES SERIES A FUNDING ROUND
Investment Closes at $1.3 Million
DURHAM, N.C. – Bioptigen, an optical technology company developing proprietary advances in the field of optical coherence tomography (OCT), announces the closing of its Series A round of funding. The round closed at $1.3 million and investors included the Piedmont Angel Network, the Inception Micro-Angel Fund and qualified individuals. Bioptigen w
Read Full Article
Login to comment.